Tumour growth kinetics assessment: added value to RECIST in cancer patients treated with molecularly targeted agents

BACKGROUND: Treatment effect is categorised into four classes by RECIST based on the evolution of the size of target lesions and the occurrence of new lesions, irrespective of tumour growth kinetics before treatment. This study aimed at evaluating the added value of tumour growth kinetics assessment...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Tourneau, C, Servois, V, Diéras, V, Ollivier, L, Tresca, P, Paoletti, X
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305968/
https://www.ncbi.nlm.nih.gov/pubmed/22281665
http://dx.doi.org/10.1038/bjc.2012.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305968/
https://www.ncbi.nlm.nih.gov/pubmed/22281665
http://dx.doi.org/10.1038/bjc.2012.10

Ejemplares similares